Subscribe

Lexaria Bioscience Corp. (LEXX)

USD0.59 +0.00 (+0.15%)
CA NASDAQ Healthcare Biotechnology
Address 100 – 740 McCurdy Road V1X 2P7
Kelowna, BC, CA
CEO Richard C. Christopher
IPO 2021-01-12
CIK 1348362 ISIN US52886N4060

Explore sections of this company profile

Also trades on NASDAQ Capital Market · LEXX (USD) NASDAQ Capital Market · LEXXW (USD)
Description

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting the bioavailability of compounds such as cannabinoids and nicotine by 5 to 10 times, and in some cannabinoid applications, by as much as 27 times, when compared to standard formulations. DehydraTECH also drastically cuts the time of onset from hours to mere minutes and effectively neutralizes unpleasant tastes. Beyond its established uses, the technology is currently under evaluation for its potential application with orally administered antiviral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and various other compounds. A notable feature of DehydraTECH is its capacity to facilitate the passage of drugs across the blood-brain barrier. The company operates a licensed internal research facility and holds a substantial intellectual property portfolio, comprising 23 granted patents and roughly 50 pending patent applications globally. Founded in 2004, Lexaria Bioscience Corp. is headquartered in Kelowna, Canada.

News Sentiment (7d)
75 Positive

Based on only 2 articles — low confidence

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.59 +0.00 (+0.15%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
149.8K
Beta
0.33
Float Shares
19.08M
Free Float %
93.3%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.92% -7.38% -8.65% -13.88% -44.77% -2.43% -40.98% -17.65% -90.49% -86.56% -86.56%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (2 ratings, all time) Buy
Price Targets & DCF
Current price
0.59
Low 1.50 +155.1%
Consensus 1.50 +155.1%
Median 1.50 +155.1%
High 1.50 +155.1%
Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year 1
1.50
+155.1%
All Time 1
1.50
+155.1%
Quality scores
Altman Z-Score
8.58
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    +52.1% Q2'26: -100.0% (vs Q2'25)
  • EPS growth Biotechnology: +29.7%
    -40.4% Q2'26: +61.9% (vs Q2'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
    -1,646.4%
  • EBIT margin Biotechnology: +0.0%
    -1,683.0%
  • ROIC Biotechnology: -16.1%
    -1,595.6% Q2'26: +0.0% (vs Q2'25)
  • Share dilution Biotechnology: -3.4%
    +45.3% Q2'26: +35.6% (vs Q2'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.01× Q2'26: -0.01× (vs Q2'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.36) × ERP
WACC = 99% × Ke + 1% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.59
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Aug 2018
actual
Aug 2019
actual
Aug 2020
actual
Aug 2021
actual
Aug 2022
actual
Aug 2023
actual
Aug 2024
actual
Aug 2025
actual
Aug 2026
1 Rev. Ana.
1 EPS Ana.
Aug 2027
1 Rev. Ana.
1 EPS Ana.
Aug 2028
1 Rev. Ana.
1 EPS Ana.
Aug 2029
1 Rev. Ana.
1 EPS Ana.
Revenue
433.3K
est: 449.2K (-3.6%)
222.6K
est: 2.00M (-88.9%)
384.5K
est: 3.80M (-89.9%)
722.7K
est: 929.1K (-22.2%)
255.4K
est: 339.0K (-24.7%)
226.2K
est: 317.5K (-28.8%)
464.3K
est: 500.0K (-7.1%)
705.9K
est: 669.0K (+5.5%)
200.0K
180.7K – 219.3K
-70.1% YoY
1.40M
1.27M – 1.54M
+601.5% YoY
1.59M
1.43M – 1.74M
+13.0% YoY
70.19M
63.42M – 76.95M
+4,328.1% YoY
EBITDA
-6.60M
est: -449.2K (-1,368.7%)
-4.00M
est: -2.00M (-100.0%)
-4.00M
est: -3.80M (-5.3%)
-4.02M
est: -929.1K (-332.3%)
-7.28M
est: -339.0K (-2,047.8%)
-6.57M
est: -317.5K (-1,968.4%)
-5.73M
est: -500.0K (-1,046.5%)
-11.82M
est: -669.0K (-1,667.4%)
-200.0K
-219.3K – -180.7K
+70.1% YoY
-1.40M
-1.54M – -1.27M
-601.5% YoY
-1.59M
-1.74M – -1.43M
-13.0% YoY
-70.19M
-76.95M – -63.42M
-4,328.1% YoY
EBIT
-6.60M
est: -449.2K (-1,369.2%)
-4.06M
est: -2.00M (-103.0%)
-4.15M
est: -3.80M (-9.2%)
-4.16M
est: -929.1K (-348.2%)
-7.38M
est: -339.0K (-2,078.1%)
-6.71M
est: -317.5K (-2,014.2%)
-5.81M
est: -500.0K (-1,061.7%)
-11.91M
est: -669.0K (-1,680.5%)
-200.0K
-219.3K – -180.7K
+70.1% YoY
-1.40M
-1.54M – -1.27M
-601.5% YoY
-1.59M
-1.74M – -1.43M
-13.0% YoY
-70.19M
-76.95M – -63.42M
-4,328.1% YoY
Net Income
-6.60M
est: -54.00M (+87.8%)
-4.10M
est: -27.00M (+84.8%)
-3.93M
est: -27.00M (+85.4%)
-4.03M
est: -17.55M (+77.1%)
-7.27M
est: -21.78M (+66.6%)
-6.66M
est: -17.91M (+62.8%)
-5.80M
est: -7.92M (+26.8%)
-11.90M
est: -12.24M (+2.8%)
-4.68M
-5.27M – -4.09M
+61.8% YoY
-5.58M
-6.28M – -4.88M
-19.2% YoY
-5.04M
-5.67M – -4.41M
+9.7% YoY
24.12M
21.10M – 27.14M
+578.6% YoY
SGA
6.51M
est: 5.15M (+26.6%)
3.64M
est: 22.91M (-84.1%)
3.98M
est: 43.53M (-90.9%)
4.97M
est: 10.64M (-53.3%)
4.96M
est: 3.88M (+27.7%)
3.06M
est: 3.64M (-15.8%)
3.85M
est: 5.43M (-29.0%)
4.35M
est: 7.26M (-40.2%)
2.17M
1.96M – 2.38M
-70.1% YoY
15.23M
13.76M – 16.70M
+601.5% YoY
17.21M
15.55M – 18.87M
+13.0% YoY
762.04M
688.56M – 835.52M
+4,328.1% YoY
EPS
-2.79
est: -3.00 (+7.0%)
-1.62
est: -1.50 (-8.0%)
-1.42
est: -1.50 (+5.3%)
-0.92
est: -0.98 (+5.6%)
-1.24
est: -1.21 (-2.5%)
-1.01
est: -1.00 (-1.5%)
-0.47
est: -0.44 (-6.8%)
-0.66
est: -0.68 (+2.9%)
-0.26
-0.29 – -0.23
+61.8% YoY
-0.31
-0.35 – -0.27
-19.2% YoY
-0.28
-0.32 – -0.24
+9.7% YoY
1.34
1.17 – 1.51
+578.6% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-28 C 2/5 1/5 1/5 1/5 4/5 1/5 3/5
2026-05-27 C 2/5 1/5 1/5 1/5 4/5 1/5 3/5
2026-05-26 C 2/5 1/5 1/5 1/5 4/5 1/5 3/5
2026-05-22 C 2/5 1/5 1/5 1/5 4/5 1/5 3/5
2026-05-21 C 2/5 1/5 1/5 1/5 4/5 1/5 3/5
2026-05-20 C 2/5 1/5 1/5 1/5 4/5 1/5 3/5
2026-05-19 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-18 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-15 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-14 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-13 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-12 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-11 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-08 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-07 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-06 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-05 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-04 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-05-01 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-04-30 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-04-29 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-04-28 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-04-27 C 2/5 1/5 1/5 1/5 3/5 1/5 3/5
2026-04-24 C- 1/5 1/5 1/5 1/5 2/5 1/5 3/5
2026-04-23 C- 1/5 1/5 1/5 1/5 2/5 1/5 3/5
2026-04-22 C- 1/5 1/5 1/5 1/5 2/5 1/5 3/5
2026-04-21 C- 1/5 1/5 1/5 1/5 2/5 1/5 3/5
2026-04-20 C- 1/5 1/5 1/5 1/5 2/5 1/5 3/5
2026-04-17 C- 1/5 1/5 1/5 1/5 2/5 1/5 3/5
2026-04-16 C- 1/5 1/5 1/5 1/5 2/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-9.60M
OE per share TTM
-0.47
Owner's Yield
-65.22%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
106.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
28
Total invested
1.17M
Insider transactions (90d)
0
Beneficial owners (>5%)
4
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 CHRISTOPHER BUNKA 5.34M 43.26% 5.34M 5.34M 10.00 IN CANADIAN 2010-02-08
2 C.A.B. FINANCIAL SERVICE LTD. 4.05M 32.78% 4.05M 4.05M 10.00 CO C.A.B. Financial Service Ltd. is incorporated under the Business Corporations Act (British Columbia) 2010-02-08
3 Wayne W. Boos 450.0K 5.56% 52.9K 10.00 IN 2023-09-18
4 L1 Capital Global Opportunities Master Fund Ltd. 159.0K 2.60% 159.0K 159.0K FI Cayman Islands 2022-02-14

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
28
+7 vs prev Q
New positions
10
Closed positions
3
Increased
12
Reduced
7
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 INVENOMIC CAPITAL MANAGEMENT LP 470.9K -6.3K (-1.3%) 290.6K -164.1K (-36.1%) 2.20% -0.405 pp 0.01% -0.009 pp USD2.89 -78.5% 20 qtrs
2 UBS GROUP AG 361.3K +354.2K (+4,995.9%) 222.9K +216.2K (+3,199.1%) 1.69% +1.652 pp 0.00% +0.000 pp USD0.62 +0.0% 5 qtrs
3 VANGUARD GROUP INC 258.8K +— (+0.0%) 159.7K -87.0K (-35.3%) 1.21% -0.204 pp 0.00% +0.000 pp USD2.33 -73.4% 19 qtrs
4 GEODE CAPITAL MANAGEMENT, LLC 219.7K +44.9K (+25.7%) 135.6K -31.0K (-18.6%) 1.03% +0.073 pp 0.00% +0.000 pp USD3.27 -81.0% 19 qtrs
5 TORONTO DOMINION BANK 140.0K +— (+0.0%) 86.5K -47.0K (-35.2%) 0.66% -0.110 pp 0.00% 0.000 pp USD1.65 -62.4% 4 qtrs
6 BYRNE ASSET MANAGEMENT LLC 105.5K +74.2K (+236.8%) 65.1K +35.3K (+118.2%) 0.49% +0.322 pp 0.04% +0.018 pp USD0.99 -37.4% 6 qtrs
7 STATE STREET CORP 39.3K +— (+0.0%) 24.2K -13.2K (-35.2%) 0.18% -0.031 pp 0.00% +0.000 pp USD3.42 -81.9% 8 qtrs
8 BLACKROCK, INC. 27.4K +— (+0.0%) 16.9K -9.2K (-35.2%) 0.13% -0.022 pp 0.00% +0.000 pp USD3.05 -79.7% 6 qtrs
9 KRILOGY FINANCIAL LLC 19.7K +— (+0.0%) 16.0K -5.2K (-24.6%) 0.09% -0.016 pp 0.00% 0.000 pp USD0.95 -34.7% 2 qtrs
10 NORTHERN TRUST CORP 18.4K +— (+0.0%) 11.3K -6.2K (-35.2%) 0.09% -0.015 pp 0.00% +0.000 pp USD3.42 -81.9% 8 qtrs
11 RENAISSANCE TECHNOLOGIES LLC 15.6K +5.5K (+54.5%) 9.6K +3.0 (+0.0%) 0.07% +0.018 pp 0.00% +0.000 pp USD0.83 -25.3% 2 qtrs
12 BANK OF MONTREAL /CAN/ 14.1K +50.0 (+0.4%) 8.7K -4.6K (-34.8%) 0.07% -0.011 pp 0.00% +0.000 pp USD3.04 -79.6% 6 qtrs
13 ROYAL BANK OF CANADA 7.3K +— (+0.0%) 4.0K -3.0K (-42.9%) 0.03% -0.006 pp 0.00% +0.000 pp USD3.42 -81.9% 8 qtrs
14 ADVISOR GROUP HOLDINGS, INC. 2.2K +5.0 (+0.2%) 1.4K -757.0 (-35.8%) 0.01% -0.002 pp 0.00% +0.000 pp USD3.20 -80.6% 20 qtrs
15 FEDERATION DES CAISSES DESJARDINS DU QUEBEC 382.00 +— (+0.0%) 233.00 -129.0 (-35.6%) 0.00% 0.000 pp 0.00% +0.000 pp USD1.71 -63.7% 4 qtrs
16 BANK OF AMERICA CORP /DE/ 203.00 +30.0 (+17.3%) 126.00 -38.0 (-23.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.32 -73.3% 8 qtrs
17 MAI CAPITAL MANAGEMENT 200.00 +200.0 (+100.0%) 124.00 +124.0 (+100.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD0.62 +0.0% 1 qtrs NEW
18 FARTHER FINANCE ADVISORS, LLC 166.00 +— (+0.0%) 102.00 -56.0 (-35.4%) 0.00% 0.000 pp 0.00% +0.000 pp USD2.72 -77.2% 12 qtrs
19 TOWER RESEARCH CAPITAL LLC (TRC) 32.00 -3.6K (-99.1%) 20.00 -3.4K (-99.4%) 0.00% -0.020 pp 0.00% 0.000 pp USD1.22 -49.2% 19 qtrs
20 GABLES CAPITAL MANAGEMENT INC. 13.00 +— (+0.0%) 8.00 -4.0 (-33.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.92 -32.6% 13 qtrs
21 MORGAN STANLEY 3.00 +3.0 (+100.0%) 2.00 +2.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.33 +87.9% 1 qtrs NEW
22 ROCKEFELLER CAPITAL MANAGEMENT L.P. -200.0 (-100.0%) -191.0 (-100.0%) 0.00% -0.001 pp 0.00% +0.000 pp USD 2 qtrs SOLD
23 PNC FINANCIAL SERVICES GROUP, INC. -6.0 (-100.0%) -6.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
24 MURCHINSON LTD. -419.6K (-100.0%) -399.7K (-100.0%) 0.00% -2.293 pp 0.00% -0.051 pp USD 2 qtrs SOLD
25 CITIGROUP INC -429.0 (-100.0%) -409.0 (-100.0%) 0.00% -0.002 pp 0.00% +0.000 pp USD 2 qtrs SOLD
26 VIRTU FINANCIAL LLC -29.4K (-100.0%) -28.0K (-100.0%) 0.00% -0.161 pp 0.00% -0.002 pp USD 2 qtrs SOLD
27 WEALTH ENHANCEMENT ADVISORY SERVICES, LLC -35.8K (-100.0%) -29.9K (-100.0%) 0.00% -0.196 pp 0.00% +0.000 pp USD 8 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Vanguard Extended Market ETF VXF 0.00% 175.6K 0.05%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
Shares disposed
100.0K
Cash buys
Cash sales
Net activity
-100,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-17 BUNKA CHRISTOPHER Director G-Gift D common shares 100,000 0.00 273,543 D
2025-07-30 BUNKA CHRISTOPHER Director P-Purchase A common shares 11,900 0.91 10.9K 281,912 I
2025-07-29 McKechnie William Edward Director P-Purchase A common shares 5,000 0.91 4.5K 18,191 D
2025-07-29 DOCHERTY JOHN MARTIN Director / Officer P-Purchase A common shares 5,376 0.93 5.0K 5,376 D
2025-07-29 Carle Vanessa Officer P-Purchase A common shares 750 0.91 682.50 750 D
2025-07-29 CHRISTOPHER RICHARD Director / Officer P-Purchase A common shares 15,000 0.91 13.6K 65,000 D
2025-07-29 BUNKA CHRISTOPHER Director P-Purchase A common shares 15,600 0.92 14.4K 270,012 I
2025-05-15 Shankman Michael Elliot Officer A-Award A Stock Options 50,000 1.04 52.0K 100,000 D
2025-05-15 REESE ALBERT L JR Director A-Award A Stock Options 11,000 1.04 11.4K 43,000 D
2025-05-15 DOCHERTY JOHN MARTIN Director / Officer A-Award A Stock Options 150,000 1.04 156.0K 310,834 D
2025-05-15 Carle Vanessa Officer A-Award A Stock Options 15,000 1.04 15.6K 75,000 D
2025-05-15 CHRISTOPHER RICHARD Director / Officer A-Award A Stock Options 150,000 1.04 156.0K 350,000 D
2025-05-15 Bhullar Baljinder Director A-Award A Stock Options 11,000 1.04 11.4K 11,000 D
2025-05-15 Baxter Nicholas W Director A-Award A Stock Options 11,000 1.04 11.4K 63,000 D
2025-05-15 BUNKA CHRISTOPHER Director A-Award A Stock Options 11,000 1.04 11.4K 184,834 D
2025-02-28 Shankman Michael Elliot Officer Stock Options 50,000 3.17 158.5K 0 D
2025-02-28 CHRISTOPHER RICHARD Officer D Stock Options 200,000 3.92 784.0K 0
2025-01-14 Bhullar Baljinder Director common shares 0 0.00 13,000 D
2025-01-07 BUNKA CHRISTOPHER Director A-Award A Restricted Stock Award 100,000 0.00 373,543 D
2024-12-03 CHRISTOPHER RICHARD Officer P-Purchase A common shares 27,172 2.47 67.2K 50,000 D
2024-12-02 CHRISTOPHER RICHARD Officer P-Purchase A common shares 22,828 2.24 51.2K 22,828 D
2024-08-12 TURKEL CATHERINE C. Director P-Purchase A common shares 1,600 3.13 5.0K 3,100
2024-07-31 Carle Vanessa Officer S-Sale D common shares 2,567 4.00 10.3K 0
2024-07-26 TURKEL CATHERINE C. Director A-Award A Stock Options 12,000 3.39 40.7K 27,000
2024-07-26 REESE ALBERT L JR Director A-Award A Stock Options 12,000 3.39 40.7K 32,000
2024-07-26 McKechnie William Edward Director A-Award A Stock Options 12,000 3.39 40.7K 52,000
2024-07-26 Baxter Nicholas W Director A-Award A Stock Options 12,000 3.39 40.7K 52,000
2024-05-14 Carle Vanessa Officer M-Exempt D Stock Options 2,500 1.15 2.9K 60,067
2024-04-26 TURKEL CATHERINE C. Director A-Award A Stock Options 5,000 2.36 11.8K 15,000
2024-04-26 REESE ALBERT L JR Director A-Award A Stock Options 5,000 2.36 11.8K 20,000
2024-04-26 McKechnie William Edward Director A-Award A Stock Options 5,000 2.36 11.8K 40,000
2024-04-26 DOCHERTY JOHN MARTIN Director / Officer A-Award A Stock Options 49,500 2.36 116.8K 174,168
2024-04-26 Carle Vanessa Officer A-Award A Stock Options 10,000 2.36 23.6K 62,567
2024-04-26 Baxter Nicholas W Director A-Award A Stock Options 5,000 2.36 11.8K 40,000
2024-04-26 BUNKA CHRISTOPHER Director / Officer A-Award A Stock Options 49,500 2.36 116.8K 180,501
2024-03-15 Cabatuan Nelson Officer D Stock Options 200,000 2.93 586.0K 0
2023-10-26 DOCHERTY JOHN MARTIN Director / Officer A-Award A Stock Options 30,000 1.15 34.5K 124,668
2023-10-26 Carle Vanessa Officer A-Award A Stock Options 12,500 1.15 14.4K 52,567
2023-10-26 BUNKA CHRISTOPHER Director / Officer A-Award A Stock Options 30,000 1.15 34.5K 131,001
2023-07-25 TURKEL CATHERINE C. Director A-Award A Stock Options 5,000 0.87 4.4K 10,000
2023-07-25 REESE ALBERT L JR Director A-Award A Stock Options 5,000 0.87 4.4K 15,000
2023-07-25 McKechnie William Edward Director A-Award A Stock Options 5,000 0.87 4.4K 35,000
2023-07-25 Baxter Nicholas W Director A-Award A Stock Options 5,000 0.87 4.4K 35,000
2023-04-15 Downey Gregory Officer D Stock Options 4,000 5.04 20.2K 0
2023-02-09 TURKEL CATHERINE C. Director P-Purchase A Common Shares 1,500 2.84 4.3K 1,500
2022-10-14 Downey Gregory Officer P-Purchase A common shares 121 2.09 252.89 1,954
2022-10-13 BUNKA CHRISTOPHER Officer A-Award A common shares 16,600 2.10 34.9K 254,412
2022-10-12 TURKEL CATHERINE C. Director A-Award A Stock Options 1,600 0.00 5,000
2022-10-12 REESE ALBERT L JR Director A-Award A Stock Options 3,200 0.00 10,000
2022-10-12 McKechnie William Edward Director A-Award A Stock Options 18,200 0.00 30,000
2022-10-12 Baxter Nicholas W Director A-Award A Stock Options 18,200 0.00 30,000
2022-10-12 BUNKA CHRISTOPHER Officer A-Award A common shares 21,900 1.99 43.5K 237,812
2022-09-02 TURKEL CATHERINE C. Director A-Award A Stock Options 3,400 0.00 3,400
2022-08-29 Downey Gregory Officer A-Award A Stock Options 11,000 0.00 46,000
2022-08-29 DOCHERTY JOHN MARTIN Officer A-Award A Stock Options 30,000 0.00 94,668
2022-08-29 Carle Vanessa Officer A-Award A Stock Options 12,500 0.00 40,067
2022-08-29 BUNKA CHRISTOPHER Officer A-Award A Stock Options 30,000 0.00 101,001
2022-05-24 REESE ALBERT L JR Director A-Award A common shares 5,000 1.96 9.8K 10,917
2022-05-20 REESE ALBERT L JR Director A-Award A common shares 1,799 2.01 3.6K 5,917
2022-05-19 REESE ALBERT L JR Director A-Award A common shares 1,501 2.01 3.0K 4,118
2022-05-18 REESE ALBERT L JR Director A-Award A common shares 1,700 2.01 3.4K 2,617
2022-03-08 REESE ALBERT L JR Director A-Award A Stock Options 3,400 0.00 6,800
2022-03-08 McKechnie William Edward Director A-Award A Stock Options 3,400 0.00 11,800
2022-03-08 Baxter Nicholas W Director A-Award A Stock Options 3,400 3.39 11.5K 11,800
2021-09-01 McKechnie William Edward Director A-Award A Stock Options 1,900 6.23 11.8K 8,400
2021-09-01 Downey Gregory Officer A-Award A Stock Options 10,000 6.23 62.3K 35,000
2021-09-01 DOCHERTY JOHN MARTIN Director / Officer A-Award A Stock Options 15,000 6.23 93.5K 64,668
2021-09-01 Carle Vanessa Officer A-Award A Stock Options 10,000 6.23 62.3K 27,567
2021-09-01 Baxter Nicholas W Director A-Award A Stock Options 1,900 6.23 11.8K 8,400
2021-09-01 BUNKA CHRISTOPHER Director / Officer A-Award A Stock Options 15,000 6.23 93.5K 71,001
2021-06-08 McKechnie William Edward Director A-Award A Stock Options 5,000 7.08 35.4K 6,500
2021-06-08 Downey Gregory Officer A-Award A Stock Options 8,000 7.08 56.6K 25,000
2021-06-08 DOCHERTY JOHN MARTIN Director / Officer A-Award A Stock Options 18,334 7.08 129.8K 49,668
2021-06-08 Carle Vanessa Officer A-Award A Stock Options 5,000 7.08 35.4K 17,567
2021-06-08 Baxter Nicholas W Director A-Award A Stock Options 5,000 7.08 35.4K 6,500
2021-06-08 BUNKA CHRISTOPHER Director / Officer A-Award A Stock Options 23,334 7.08 165.2K 56,001
2021-05-07 McKechnie William Edward Director J-Other D Stock Options 5,000 9.60 48.0K 1,500
2021-05-07 Downey Gregory Officer J-Other D Stock Options 8,000 9.60 76.8K 17,000
2021-05-07 DOCHERTY JOHN MARTIN Director / Officer J-Other D Stock Options 18,334 14.10 258.5K 31,334
2021-05-07 Carle Vanessa Officer J-Other D Stock Options 5,000 9.60 48.0K 12,567
2021-05-07 Baxter Nicholas W Director J-Other D Stock Options 5,000 9.60 48.0K 1,500
2021-05-07 BUNKA CHRISTOPHER Director / Officer J-Other D Stock Options 23,334 10.20 238.0K 32,667
2021-04-26 McKechnie William Edward Director A-Award A Stock Options 1,500 5.31 8.0K 6,500
2021-04-26 Downey Gregory Officer A-Award A Stock Options 5,000 5.31 26.6K 25,000
2021-04-26 DOCHERTY JOHN MARTIN Director / Officer A-Award A Stock Options 18,000 5.31 95.6K 49,668
2021-04-26 Carle Vanessa Officer A-Award A Stock Options 12,500 5.31 66.4K 17,567
2021-04-26 Baxter Nicholas W Director A-Award A Stock Options 1,500 5.31 8.0K 6,500
2021-04-26 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A Stock Options 26,000 5.83 151.6K 56,001
2021-04-15 Downey Gregory Officer D common shares 0 0.00 1,833
2021-04-15 Carle Vanessa Officer D common shares 0 0.00 67
2021-02-01 REESE ALBERT L JR Director A-Award A Stock Options 3,400 4.80 16.3K 3,400
2021-01-14 REESE ALBERT L JR Director D common shares 0 0.00 917
2020-11-10 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A common shares 25,500 0.19 4.8K 6,477,344
2020-11-09 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A common shares 22,000 0.20 4.4K 6,435,844
2020-11-06 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A common shares 60,000 0.21 12.3K 6,341,844
2020-07-23 McKechnie William Edward Director M-Exempt D Stock Options 110,000 0.17 19.0K 150,000
2020-05-06 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A Warrants 200,000 0.35 70.0K 200,000
2020-04-23 Spissinger Allan Horst Officer A-Award A stock options 650,000 0.32 208.0K 650,000
2020-04-23 Quigley Brian W. Director A-Award A stock options 100,000 0.32 32.0K 100,000
2020-04-23 McKechnie William Edward Director A-Award A stock options 150,000 0.32 48.0K 260,000
2020-04-23 Downey Gregory Officer D Stock Options 8,000 9.60 76.8K 0
2020-04-23 DOCHERTY JOHN MARTIN Director / Officer A-Award A stock options 400,000 0.32 128.0K 1,250,000
2020-04-23 Carle Vanessa Officer D Stock Options 5,000 9.60 48.0K 0
2020-04-23 Baxter Nicholas W Director A-Award A stock options 150,000 0.32 48.0K 150,000
2020-04-23 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A stock options 700,000 0.34 238.0K 700,000
2020-03-23 Spissinger Allan Horst Officer J-Other D stock options 300,000 1.53 459.0K 0
2020-03-23 Quigley Brian W. Director J-Other D stock options 100,000 0.81 81.0K 0
2020-03-23 McKechnie William Edward Director J-Other D stock options 150,000 0.99 148.5K 110,000
2020-03-23 DOCHERTY JOHN MARTIN Director / Officer J-Other D stock options 400,000 1.53 612.0K 850,000
2020-03-23 Baxter Nicholas W Director J-Other D stock options 150,000 0.99 148.5K 0
2020-03-23 BUNKA CHRISTOPHER Director / Officer / 10% Owner J-Other D stock options 700,000 1.53 1.07M 0
2020-02-07 DOCHERTY JOHN MARTIN Director / Officer A-Award A Stock Options 550,000 0.47 258.5K 1,250,000
2019-12-30 DOCHERTY JOHN MARTIN Director / Officer J-Other A Stock Options 550,000 0.09 49.5K 700,000
2019-12-20 Baxter Nicholas W Director M-Exempt A common shares 110,000 0.10 11.0K 330,000
2019-11-13 Carle Vanessa Officer D Warrants 67 36.00 2.4K 0
2019-08-15 Quigley Brian W. Director A-Award A Stock Options 100,000 0.81 81.0K 100,000
2019-05-06 McKechnie William Edward Director A-Award A Stock Options 150,000 0.99 148.5K 260,000
2019-05-06 Baxter Nicholas W Director A-Award A Stock Options 150,000 0.99 148.5K 260,000
2019-04-05 McKechnie William Edward Director J-Other A Stock Options 50,000 0.17 8.5K 110,000
2019-04-05 Baxter Nicholas W Director J-Other D Stock Options 50,000 1.53 76.5K 10,000
2019-04-05 BUNKA CHRISTOPHER Director / Officer / 10% Owner J-Other D Stock Options 550,000 0.10 55.0K 700,000
2019-02-15 Spissinger Allan Horst Officer M-Exempt D Stock Options 50,000 0.37 18.5K 650,000
2018-08-31 DOCHERTY JOHN MARTIN Director / Officer A-Award A Common Shares 36,500 2.07 75.6K 1,622,250
2018-08-31 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A Common Shares 32,500 2.07 67.3K 7,126,304
2018-08-14 BUNKA CHRISTOPHER Director / Officer / 10% Owner G-Gift D Common Shares 500,000 0.00 7,093,804
2018-08-03 DOCHERTY JOHN MARTIN Director / 10% Owner A-Award A Common Shares 91,250 1.24 113.2K 1,585,750
2018-08-03 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A Common Shares 81,250 1.24 100.8K 7,593,804
2018-06-18 BUNKA CHRISTOPHER Director / Officer / 10% Owner M-Exempt A Common Shares 247,500 0.09 22.3K 7,512,554
2018-05-31 Spissinger Allan Horst Officer A-Award A Stock Options 300,000 1.53 459.0K 700,000
2018-05-31 McKechnie William Edward Director S-Sale D Common Shares 2,100 1.90 4.0K 285,738
2018-05-31 DOCHERTY JOHN MARTIN Director / 10% Owner A-Award A Stock Options 400,000 1.53 612.0K 1,250,000
2018-05-31 Baxter Nicholas W Director P-Purchase A Options 50,000 1.53 76.5K 160,000
2018-05-31 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A Stock Options 700,000 1.53 1.07M 1,497,500
2018-05-30 McKechnie William Edward Director S-Sale D Common Shares 47,800 1.90 90.8K 287,938
2017-12-01 Spissinger Allan Horst Officer A-Award A Stock Options 200,000 0.83 166.0K 400,000
2017-12-01 McKechnie William Edward Director A-Award A Common Shares 14,634 0.82 12.0K 335,738
2017-12-01 DOCHERTY JOHN MARTIN Director / 10% Owner A-Award A Common Shares 35,000 0.82 28.7K 1,312,000
2017-12-01 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A Common Shares 29,475 0.82 24.2K 7,265,054
2017-08-28 McKechnie William Edward Director A-Award A Common Shares 32,433 0.37 12.0K 321,104
2017-06-22 DOCHERTY JOHN MARTIN Director / Officer A-Award A Common Shares 210,000 0.30 62.0K 1,277,000
2017-06-21 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A Common Shares 210,000 0.30 62.0K 5,631,844
2017-06-01 Spissinger Allan Horst Officer A-Award A Stock Options 200,000 0.38 76.0K 200,000
2017-05-31 McKechnie William Edward Director A-Award A Common Shares 35,249 0.34 12.0K 288,626
2017-05-15 DOCHERTY JOHN MARTIN Director / Officer J-Other D Warrants 143,000 0.23 32.9K 0
2017-02-22 McKechnie William Edward Director A-Award A Common Shares 29,091 0.55 16.0K 253,377
2016-10-11 McKechnie William Edward Director A-Award A Common Shares 114,286 0.14 16.0K 224,286
2016-10-11 DOCHERTY JOHN MARTIN Director / Officer A-Award A Common Shares 252,000 0.14 35.3K 1,067,000
2016-10-07 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.12 600.00 7,235,579
2016-10-05 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,500 0.15 362.50 7,215,579
2016-08-26 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,100 0.13 652.80 7,213,079
2016-08-25 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.14 700.00 7,207,979
2016-08-24 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 3,000 0.13 375.00 7,183,342
2016-08-22 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 9,300 0.13 1.2K 7,180,342
2016-08-19 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 10,500 0.13 1.3K 7,171,042
2016-08-18 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,000 0.15 300.00 7,160,542
2016-08-12 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 10,000 0.15 1.5K 7,147,202
2016-08-11 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 450,000 0.06 27.0K 5,421,844
2016-08-04 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.13 645.00 7,137,202
2016-07-25 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.15 735.00 7,132,202
2016-07-22 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 1,100 0.12 132.00 7,108,119
2016-07-18 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 7,000 0.14 952.00 7,100,619
2016-07-15 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 6,000 0.12 716.40 7,068,619
2016-07-14 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.14 675.00 7,045,114
2016-07-13 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,000 0.11 210.00 7,031,314
2016-07-07 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 4,000 0.14 540.00 7,019,314
2016-07-06 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 50,000 0.09 4.4K 7,010,314
2016-04-29 Bhullar Baljinder 0 0.00 0
2016-04-15 DOCHERTY JOHN MARTIN Director / Officer P-Purchase A Stock Options 300,000 0.11 33.0K 850,000
2016-02-16 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 12,000 0.10 1.2K 6,955,314
2016-01-15 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.12 620.00 6,943,314
2016-01-13 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,000 0.14 280.00 6,938,314
2016-01-12 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 12,500 0.14 1.7K 6,936,314
2016-01-11 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.14 720.00 4,971,844
2016-01-07 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.15 755.00 4,966,844
2016-01-06 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 3,990 0.15 602.49 4,961,844
2016-01-04 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.18 900.00 4,957,854
2015-12-24 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,000 0.20 400.00 6,908,814
2015-12-23 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 1,500 0.20 300.00 6,906,814
2015-12-21 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,500 0.20 500.00 6,905,314
2015-12-18 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 15,000 0.21 3.1K 6,894,314
2015-12-17 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,500 0.20 500.00 6,879,314
2015-12-16 McKechnie William Edward Director A-Award A Stock Options 10,000 0.17 1.7K 110,000
2015-12-16 DOCHERTY JOHN MARTIN Officer A-Award A Warrants 13,000 0.23 3.0K 143,000
2015-12-16 Bhullar Baljinder Director / Officer A-Award A Common Shares 14,125 0.00 155,375
2015-12-16 Baxter Nicholas W Director A-Award A Common Shares 20,000 0.00 220,000
2015-12-16 BUNKA CHRISTOPHER Director / Officer / 10% Owner A-Award A Common Shares 624,938 0.00 6,874,314
2015-12-10 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.20 975.00 6,249,376
2015-12-08 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 1,000 0.20 203.00 6,244,376
2015-12-04 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.20 1.0K 6,240,376
2015-12-03 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 5,000 0.19 955.00 6,217,376
2015-12-02 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 7,000 0.20 1.4K 6,207,376
2015-11-27 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 1,000 0.22 220.00 6,200,376
2015-11-25 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 6,500 0.21 1.4K 6,176,376
2015-11-24 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,500 0.23 582.50 6,169,876
2015-11-23 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 1,500 0.26 384.00 6,167,376
2015-11-20 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,500 0.22 550.00 6,165,876
2015-11-19 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 1,000 0.22 220.00 6,163,376
2015-11-18 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,500 0.21 517.25 6,153,876
2015-11-17 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 2,600 0.21 538.20 6,145,876
2015-11-16 BUNKA CHRISTOPHER Director / Officer / 10% Owner P-Purchase A Common Shares 200 0.20 39.80 6,133,976

Executive team

Top executives
EBIT / Employee
-17.0K
Shares Outstanding
20.44M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2011 Christopher Bunka , President, Chief Executive Officer, & Former Chief Financial Officer (Principal Executive Officer) 96.0K 51.4K 147.4K 34.85%
2 2010 Christopher Bunka , President, Chief Executive Officer, & Former Chief Financial Officer (Principal Executive Officer) 97.2K 71.3K 168.5K 42.32%
3 2009 Christopher Bunka , President, Chief Executive Officer, & Former Chief Financial Officer (Principal Executive Officer) 117.7K 12.4K 130.1K 9.53%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-12-10 DEF 14A
2024-11-27 DEF 14A
2024-11-12 PRE 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-04-13 10-Q
2026-03-18 4
2026-02-06 8-K
2026-01-28 S-8
2026-01-28 8-K
2026-01-14 EFFECT
2026-01-14 424B3
2026-01-14 25-NSE
2026-01-13 10-Q
2025-12-29 S-3

Executive team

NameTitleCompensationGender
Richard C. Christopher Chief Executive Officer & Director 519.5K male
John Docherty Chairman of the Scientific Advisory Board, Chief Scientific Officer, President & Director 430.5K male
Michael Shankman Chief Financial Officer 131.2K male
C. Michael Gibson Chief Medical Advisor & Member of Scientific Advisory Board
Kristin Hamilton Director of Operations female
Vanessa Carle Head of Legal female
ESG Rating
B+
BIOTECHNOLOGY
2024
E (Environmental)
68.5 / 56.3
Company / Sector avg.
S (Social)
61.7 / 62.4
Company / Sector avg.
G (Governance)
63.0 / 60.9
Company / Sector avg.
ESG Total
64.4 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits